β2-Adrenergic Receptor Polymorphism and Obesity in Type 2 Diabetes
Response to van Tilburg et al.
- Keiji Yoshioka, MD1,
- Toshihide Yoshida, MD2 and
- Toshikazu Yoshikawa, MD2
- 1Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi, Osaka, Japan
- 2Department of Diabetes, Endocrinology, and Metabolism, Kyoto Prefectural University of Medicine, Koyto, Japan
We read with interest the observation letter by van Tilburg et al. (1) reporting that the Glu27Gln polymorphism of the β2-adrenergic receptor (B2ADR) has no important effect on BMI, metabolic control, or plasma lipids. However, the authors did not mention the physical activity …
